Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02465307
Other study ID # IRB201400546 -N
Secondary ID 17501921R21EB027
Status Active, not recruiting
Phase
First received
Last updated
Start date February 2016
Est. completion date May 30, 2025

Study information

Verified date June 2024
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Delirium, as a common complication of hospitalization, poses significant health problems in hospitalized patients. Though about a third of delirium cases can benefit from intervention, detecting and predicting delirium is still very limited in practice. A common characterization of delirium is change in activity level, causing patients to become hyperactive or hypoactive which is manifested in facial expressions and total body movements. This pilot study is designed to test the feasibility of a delirium detection system using movement data obtained from 3-axis wearable accelerometers and commercially available camera with facial recognition video system in conjunction with electronics medical record (EMR) data to analyze the relation of whole-body movement and facial expressions with delirium.


Description:

The aim of the study is to assess the potential of using motion and facial expression data to detect delirium in ICU patients by comparing motion and facial expression patterns in delirium and control groups. In this study, the investigators will use ActiGraph accelerometers to record each subject's movement patterns. Also, a processed video using a commercially available camera interfaces with a specialized program to identify patient facial expressions and movement patterns. A total of 60 participants will be enrolled with delirium, and 30 patients without delirium will be used as control group. Motion profiles will be compared in the motorically defined subgroups (hyperactive, hypoactive, normal) based on accelerometer and facial recognition data. Then, differences in facial expression, number of changes in postures, and percentage of time spent moving will be compared between motorically defined subgroups and in delirium and control groups. EMR data will also be used to assess the feasibility of detecting delirium by including additional information on related risk factors.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 130
Est. completion date May 30, 2025
Est. primary completion date March 11, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria (ICU Patients): - Intensive care unit patient - 18 years of age or older Exclusion Criteria (ICU Patients): - Anticipated intensive care unit stay less than one day - Less than 18 years of age - Inability to wear a motion sensor watch (ActiGraph) Inclusion Criteria (Healthy Controls): - 18 years of age or older. - sleeps in home environment Exclusion Criteria (Healthy Controls): - does not sleep in home environment - Less than 18 years of age - Inability to wear a motion sensor watch (ActiGraph)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Confusion Assessment Method
Confusion Assessment Method (CAM) score
Device:
Accelerometer
3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor
Commercially available camera
As part of facial recognition video system
Internet Pod (iPod)
Monitors noise levels in the room
Diagnostic Test:
Cortisol Swab
Cortisol level collected through self administered salivary swab

Locations

Country Name City State
United States UF Health Gainesville Florida

Sponsors (4)

Lead Sponsor Collaborator
University of Florida National Institute for Biomedical Imaging and Bioengineering (NIBIB), National Institute of Neurological Disorders and Stroke (NINDS), U.S. National Science Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Facial amimia versus non-amimia expressions between the groups Frequency of presence of facial amimia versus non-amimia expressions between the groups. Changes from Baseline up to 7 Days
Other Dynamic activity versus static position Percentage of time spent moving versus static position Changes from Baseline up to 7 Days
Primary CAM/CAM-ICU Confusion Assessment Method for detection of delirium Changes from Baseline up to 7 Days
Primary Memorial Delirium Assessment Scale (MDAS) will be used for changes from baseline up to 7 days between the groups. MDAS denotes motor profile and defines motor subtyping. It has 10 items which assesses several areas of cognitive functioning (memory, attention, orientation and disturbances in thinking) and psychomotor activity. The items are rated on a four point scale (0-3) based on the current interaction with the patient or by assessment of behavior. A score of 13 shows the diagnosis of delirium. Changes from Baseline up to 7 Days
Primary Delirium Motor Subtyping Scale (DMSS-4) will be used for changes from baseline up to 7 days between the groups. Scoring from DMSS-4 which has 5 hyperactive and 8 hypoactive symptoms requires at least two symptoms to be present from either the hyperactive or hypoactive list to meet subtype criteria. The higher the score the higher the delirium. Changes from Baseline up to 7 Days
Primary Freedman Sleep Scale To determine sleep quality of patient for given day. Changes from Baseline up to 7 Days
Secondary Number of subjects who died Death at any time during admission Baseline up to 7 Days
Secondary Number of subjects on mechanical ventilation Number of subjects requiring mechanical ventilation greater than 48 hours. greater than 48 hours
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A